Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· November 27, 2025

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035 Ottawa, Nov…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

IV route accounts for 90% of ADC administration in 2024
80% confidence
Asia-Pacific is the fastest growing ADC market region
80% confidence
Generic/biosimilar ADCs are the fastest growing drug type segment
80% confidence
Cleavable linkers represent 60% of ADC linker market share in 2024
80% confidence
Cytotoxic payloads represent 70% of ADC payload market share in 2024
80% confidence
Global antitumor ADC drugs market will grow from $8.33B in 2026 to $24.75B in 2035 at 12.86% CAGR
80% confidence
Solid tumors represent the fastest growing therapeutic area for ADCs
80% confidence
Branded ADC drugs represent 75% market share in 2024
80% confidence
Hematologic cancers represent 35% of ADC therapeutic area market in 2024
80% confidence
Hospital pharmacies and oncology centers represent 70% of ADC distribution in 2024
80% confidence
North America holds 55% revenue share of ADC market in 2024
80% confidence